Stempoint Capital »

Perceptive Cap Solutions Cor Cl A shares owned by Stempoint Capital

Quarter-by-quarter ownership of Perceptive Cap Solutions Cor Cl A (PCSC) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Perceptive Cap Solutions Cor Cl A

Tip: Access up to 7 years of quarterly data

All positions including Perceptive Cap Solutions Cor Cl A held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perceptive Cap Solutions Cor Cl A by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 150k 10.02
2024-06-30 $1.5M 150k 10.06

More positions owned by Stempoint Capital

Syndax Pharmaceuticals (SNDX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Merus N V (MRUS)
Arcutis Biotherapeutics (ARQT)
Amicus Therapeutics (FOLD)
Applied Therapeutics (APLT)
Bristol Myers Squibb (BMY)
Crinetics Pharmaceuticals In (CRNX)
Biohaven (BHVN)
Praxis Precision Medicines I Com New (PRAX)
Autolus Therapeutics Spon Ads (AUTL)
Incyte Corporation (INCY)
Denali Therapeutics (DNLI)
Day One Biopharmaceuticals I (DAWN)

View all positions for Stempoint Capital

Top funds holding Perceptive Cap Solutions Cor Cl A

Commodore Capital
VR Adviser
RA Capital Management
683 Capital Management
Shaolin Capital Management
OZ Management
Affinity Asset Advisors
Kepos Capital
Point72 Asset Management
Schonfeld Strategic Advisors
Stempoint Capital
Highbridge Capital Management
Two Sigma Investments
Tenor Capital Management
Cowen And Company

View all funds holding Perceptive Cap Solutions Cor Cl A